Tag
3B BlackBio Dx Limited
3 articles
3B BlackBio Q1 Revenue Up 51% YoY to ₹33.49 Crore
3B BlackBio reported Q1 FY27 consolidated revenue of ₹33.49 crore, a 51% YoY increase, though PAT declined 29% to ₹8.98 crore.
The Molecular Diagnostics division, including recent acquisition Coris Bi
3B BlackBio Q1 FY27 Net Profit Rises 89.6% YoY
Board approved unaudited standalone and consolidated financial results for Q1 FY27, reporting a standalone net profit of ₹1,411.21 lakh.
Standalone revenue from operations grew 9.2% YoY to ₹2,824.79 l
3B BlackBio Dx Promoter Acquires 1,000 Shares
Disclosure under SEBI Regulation 29(2) regarding promoter Dhirendra Dubey's purchase of 1,000 equity shares on June 24, 2026.
Promoter holding increased from 724,098 shares (8.44%) to 725,098 shares (